Log in

NASDAQ:LVGOLivongo Health Stock Price, Forecast & News

+10.78 (+11.14 %)
(As of 07/9/2020 04:00 PM ET)
Today's Range
Now: $107.56
50-Day Range
MA: $66.16
52-Week Range
Now: $107.56
Volume9.15 million shs
Average Volume2.74 million shs
Market Capitalization$10.52 billion
P/E RatioN/A
Dividend YieldN/A
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.45 out of 5 stars

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Current SymbolNASDAQ:LVGO



Sales & Book Value

Annual Sales$170.20 million
Book Value$5.37 per share


Net Income$-55,270,000.00


Market Cap$10.52 billion
Next Earnings Date8/6/2020 (Confirmed)
OptionableNot Optionable

Receive LVGO News and Ratings via Email

Sign-up to receive the latest news and ratings for LVGO and its competitors with MarketBeat's FREE daily newsletter.

Livongo Health (NASDAQ:LVGO) Frequently Asked Questions

How has Livongo Health's stock been impacted by COVID-19 (Coronavirus)?

Livongo Health's stock was trading at $25.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LVGO shares have increased by 327.5% and is now trading at $107.56. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Livongo Health?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Livongo Health in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Livongo Health.

When is Livongo Health's next earnings date?

Livongo Health is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Livongo Health.

How can I listen to Livongo Health's earnings call?

Livongo Health will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Livongo Health's earnings last quarter?

Livongo Health (NASDAQ:LVGO) announced its quarterly earnings results on Wednesday, May, 6th. The company reported $0.03 earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.07. The business had revenue of $68.80 million for the quarter, compared to the consensus estimate of $66.11 million. Livongo Health had a negative net margin of 22.05% and a negative return on equity of 11.81%. The company's revenue was up 114.3% compared to the same quarter last year. View Livongo Health's earnings history.

What guidance has Livongo Health issued on next quarter's earnings?

Livongo Health issued an update on its second quarter 2020 Pre-Market earnings guidance on Tuesday, July, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $86-87 million, compared to the consensus revenue estimate of $74.97 million.

What price target have analysts set for LVGO?

16 brokers have issued 1-year price objectives for Livongo Health's stock. Their forecasts range from $30.00 to $120.00. On average, they anticipate Livongo Health's share price to reach $74.50 in the next year. This suggests that the stock has a possible downside of 30.7%. View analysts' price targets for Livongo Health.

What are Wall Street analysts saying about Livongo Health stock?

Here are some recent quotes from research analysts about Livongo Health stock:
  • 1. According to Zacks Investment Research, "Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. Livongo Health Inc. is based in Mountain View, United States. " (5/6/2020)
  • 2. Chardan Capital analysts commented, "We are initiating on Livongo (LVGO) with a Neutral rating and a 12-month Price Target of $40. Livongo Health (LVGO) is a provider of next-generation chronic care solutions through the employer and managed care channels. The company provides solutions to manage conditions such as diabetes, hypertension, prediabetes, and weight management, by means of smart connected devices and personalized digital guidance. Our channel checks find that Livongo is the market leader in next-generation diabetes solutions sold through the large employer channel and is well positioned to continue to sell into this large and growing market." (8/16/2019)

Has Livongo Health been receiving favorable news coverage?

Media coverage about LVGO stock has been trending negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Livongo Health earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Livongo Health.

Are investors shorting Livongo Health?

Livongo Health saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 6,470,000 shares, an increase of 54.8% from the June 15th total of 4,180,000 shares. Based on an average trading volume of 3,160,000 shares, the days-to-cover ratio is presently 2.0 days. Approximately 15.9% of the shares of the company are sold short. View Livongo Health's Current Options Chain.

Who are some of Livongo Health's key competitors?

What other stocks do shareholders of Livongo Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livongo Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Square (SQ), Advanced Micro Devices (AMD), Paypal (PYPL), Twilio (TWLO), Marvell Technology Group (MRVL), Zoom Video Communications (ZM), Alteryx (AYX) and salesforce.com (CRM).

Who are Livongo Health's key executives?

Livongo Health's management team includes the following people:
  • Mr. Glen E. Tullman, Founder & Exec. Chairman (Age 59)
  • Dr. Jennifer Schneider, Pres (Age 44)
  • Mr. James Pursley, Chief Commercial Officer (Age 39)
  • Mr. Zane M. Burke, CEO & Director (Age 53)
  • Mr. Lee A. Shapiro, Chief Financial Officer (Age 63)

When did Livongo Health IPO?

(LVGO) raised $230 million in an initial public offering on Thursday, July 25th 2019. The company issued 10,700,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

What is Livongo Health's stock symbol?

Livongo Health trades on the NASDAQ under the ticker symbol "LVGO."

Who are Livongo Health's major shareholders?

Livongo Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Spence Asset Management (0.23%) and Mount Yale Investment Advisors LLC (0.01%). Company insiders that own Livongo Health stock include Ab (Publ) Kinnevik, Christopher Bischoff, Gc Venture Lh Manager, Llc, Glen Tullman, Hemant Taneja, James Pursley, Jennifer Schneider and Lee Shapiro. View institutional ownership trends for Livongo Health.

Which major investors are buying Livongo Health stock?

LVGO stock was acquired by a variety of institutional investors in the last quarter, including Spence Asset Management, and Mount Yale Investment Advisors LLC. Company insiders that have bought Livongo Health stock in the last two years include Ab (Publ) Kinnevik, Christopher Bischoff, Gc Venture Lh Manager, Llc, and Hemant Taneja. View insider buying and selling activity for Livongo Health.

How do I buy shares of Livongo Health?

Shares of LVGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Livongo Health's stock price today?

One share of LVGO stock can currently be purchased for approximately $107.56.

How big of a company is Livongo Health?

Livongo Health has a market capitalization of $10.52 billion and generates $170.20 million in revenue each year. The company earns $-55,270,000.00 in net income (profit) each year or ($1.01) on an earnings per share basis. Livongo Health employs 471 workers across the globe.

What is Livongo Health's official website?

The official website for Livongo Health is www.livongo.com.

How can I contact Livongo Health?

Livongo Health's mailing address is 150 WEST EVELYN AVENUE SUITE 150, MOUNTAIN VIEW CA, 94041. The company can be reached via phone at 866-435-5643 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.